T-CELL LEUKEMIA
Clinical trials for T-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell therapy takes aim at Hard-to-Treat T-Cell cancers
Disease control Recruiting nowThis early-phase trial is testing a new type of immune therapy called CD4CAR for people with T-cell lymphoma or leukemia that has come back or not responded to treatment. The therapy uses a patient's own immune cells, which are modified in a lab to recognize and attack cancer cel…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can a cancer drug stop leukemia before it starts?
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who are at high risk. About 134 participants will receive low doses of the drug over several weeks. The goal is to see if it can reduce the virus levels…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
Scientists dig into rare blood cancer to unlock better care
Knowledge-focused Recruiting nowThis study gathers information from 50 people with T-cell prolymphocytic leukemia (T-PLL), a rare and aggressive blood cancer. Researchers will look at patients' medical records, lab results, and genetic data to better understand the disease and how it responds to current treatme…
Matched conditions: T-CELL LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC